Category: | Intermediates/Pharmaceutical intermediates |
|
|
CAS NO: | 86401-80-1 | ||
EC NO: | |||
Molecular Formula: | C23H30O7 | ||
Molecular Weight: | 418.4801 | ||
Specification: | |||
InChI: | InChI=1/C23H30O7/c1-11-5-6-16-21(2,3)19(27)15(26)9-22(16,4)23(11)8-13-14(25)7-12(10-24)17(20(28)29)18(13)30-23/h7,10-11,15-16,19,25-27H,5-6,8-9H2,1-4H3,(H,28,29)/t11-,15-,16?,19-,22+,23-/m1/s1 | ||
Product description: Product Name: 11β,16α,17α,21-Tetrahydroxyl pregn-1,4diene-3,20-dione-21-acetate Cas No.: 86401-80-1 Molecular Structure: Appearance: Almost white solid powder Purity: ≥92.0% Memo: Usage:Desonide/(R)-Budesonide intermediate |
|||
Synonyms: | 11b,16a,17,21-Tetrahydroxy-pregna-1,4-diene-3,20-dione 21-acetate;16a-Hydroxyprednisolone Acetate;(2R,2'R,6'S,7'R,8a'S)-6-formyl-4,6',7'-trihydroxy-2',5',5',8a'-tetramethyl-3',4',4a',5',6',7',8',8a'-octahydro-2'H,3H-spiro[1-benzofuran-2,1'-naphthalene]-7-carboxylic acid;16alpha-Hydroxyprednisolone acetate;11¦Â,16¦Á,17¦Á,21-Tetrahydroxyl pregn-1,4diene-3,20-dione-21-acetate; | ||
Molecular Structure: |